Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

67.00 -0.28 (-0.42%)
Streaming Delayed Price Updated: 10:51 AM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lantheus Holdings, Inc. - Common Stock

< Previous 1 2
...
16 17 18 19 20 21 22 23 Next >
News headline image
7 Stocks That Wall Street Analysts Are Loving in May ↗
Though not perfect, an analyst rating can indicate where institutional investor sentiment lies; here are seven stocks that analysts love. 
Via InvestorPlace
News headline image
Lantheus Holdings's Return On Capital Employed Overview ↗
 
Via Benzinga
News headline image
Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review ↗
The major indexes retreated for most of the week on banking fears, 
Via Investor's Business Daily
News headline image
Lantheus Holdings Earnings Perspective: Return On Capital Employed ↗
 
Via Benzinga
News headline image
Why Shares of Lantheus Holdings Rose This Week ↗
The company's fourth-quarter and full-year earnings were a pleasant surprise. 
Via The Motley Fool
News headline image
Why Synaptics Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 89.3% to $7.44. 
Via Benzinga
News headline image
Zillow, Shopify, Datadog And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded lower, with the Dow Jones falling around 400 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Why Shares of Lantheus Holdings Are Up Thursday ↗
The company reported a record quarter for revenue. 
Via The Motley Fool
News headline image
Lantheus Reports First Quarter 2023 Financial Results
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus and POINT Biopharma Announce FDA Grants Fast Track Designation for ¹⁷⁷Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer
From Lantheus Holdings, Inc.; POINT Biopharma Global Inc.
Via GlobeNewswire
News headline image
Lantheus to Host First Quarter 2023 Earnings Conference Call and Webcast on May 4, 2023, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus Announces Two Key Executive Promotions
Paul Blanchfield promoted to President; Dan Niedzwiecki promoted to Chief Administrative Officer 
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Are These Medical Device Makers Getting Ready To Rally?
Current trends and changing demographics are behind growth of medical technology companies. An aging population and a shift to in-home care are among factors. 
Via MarketBeat
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2023 ↗
 
Via Benzinga
News headline image
Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
Comfort Systems, Gannett, CommScope And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded slightly lower, with the Dow Jones dropping around 30 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Nasdaq Jumps 100 Points; US GDP Rises 2.7% In Q4 ↗
U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.35% to 33,162.00 while the NASDAQ rose 0.91%... 
Via Benzinga
News headline image
Lantheus Shares Jump On Upbeat 2023 Guidance, Q4 Earnings Surpass Expectations ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Lantheus Reports Fourth Quarter and Full Year 2022 Financial Results
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For February 23, 2023 ↗
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter. 
Via Benzinga
News headline image
Lantheus Presents Data Reinforcing Real-World Clinical Utility of Piflufolastat F 18 PET Scanning in Men with Recurrent Prostate Cancer and Low PSA Levels
Data presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium Demonstrate Potential Benefits of Piflufolastat F 18 Decision Making on Treatment Plans 
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Meet A Cannabis Executive Who Knows How To Reinvent The Business: Gary Santo Of TILT Holdings ↗
After the overwhelming success of last year's Benzinga Cannabis Capital Conference, the team is returning to Florida April 11-12, 2023 with awesome events simultan 
Via Benzinga
News headline image
Lantheus to Host Fourth Quarter and Full Year 2022 Earnings Conference Call and Webcast on February 23, 2023, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus to Present Piflufolastat F 18 Data at the 2023 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus Announces Acquisition of Cerveau Technologies, Inc., Expanding Imaging Pipeline into Alzheimer’s Disease
MK-6240 is an F 18-labeled PET imaging agent that targets Tau tangles in Alzheimer’s Disease 
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus to Present at the J.P. Morgan 2023 Healthcare Conference
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus Announces Closing of Strategic Collaboration and Exclusive License Agreements for the Commercialization of PNT2002 & PNT2003 with POINT Biopharma
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Cramer's Take On This Stock Up 48% Year-To-Date: 'I Would Not Want To Come In At This Level' ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Royal Caribbean Cruises Ltd (NYSE: RCL) is an "excellent" company. 
Via Benzinga
News headline image
Lantheus Grants Rights for the Use of its Microbubbles to SonoThera for its Ultrasound-Guided Nonviral Gene Therapy Platform
From Lantheus Holdings, Inc.
Via GlobeNewswire
< Previous 1 2
...
16 17 18 19 20 21 22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.